| PUBCHEM ID | 196 |
| Molecular Weight (mg/mol) | 146.146 |
| Molecular Formula | C6H10O4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| IUPAC Name | Adipicacid |
| Canonical SMILES | O=C(O)CCCCC(=O)O |
| PUBCHEM IUPAC INCHIKEY | WNLRTRBMVRJNCN-UHFFFAOYSA-N |
| Solubility Level | 5 |
| Vapour Pressure | -5.886 |
| XLOGP3 AA | NA |
| CACTVS TPSA | 37.29 |
| BBB Level | 3 |
| Absorption Level | 0 |
| EXT PPB#Prediction | 0 |
| AlogP98 | 0.553 |
| EXT CYP2D6#Prediction | 0 |
| Mouse Female FDA | Non-Carcinogen |
| Mouse Male FDA | Multi-Carcinogen |
| Rat Female FDA | Single-Carcinogen |
| Rat Male FDA | Multi-Carcinogen |
| Ames Prediction | Non-Mutagen |
| Developmental / Reproductive Toxicity | Non-Toxic |
| Rat Oral LD50 | 3.61844 |
| Ocular Irritancy | None |
| Hepatotoxic#Prediction | 0 |
| Effected Human Genes | NA |
| Aerobic Biodegradability Prediction | Degradable |
| Physical hazards | not classified |
| Health hazards | None |
| Environmental hazards | not classified |
| Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
|---|---|---|---|---|---|---|
| 1 | 124-04-9 | SLC22A6 | Homo sapiens | adipic acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]] | affects^cotreatment|decreases^reaction|increases^response to substance | 12606766 |
| 2 | 124-04-9 | SLC22A6 | Homo sapiens | adipic acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]] | affects^cotreatment|decreases^reaction|increases^response to substance | 12606766 |
| Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
|---|---|---|---|---|---|
| 1 | 124-04-9 | 1,4-Butanedicarboxylic acid |